Free-cash-flow proxy decreased 33.5%
Free-cash-flow proxy changed -33.5% from the comparable as-filed period.
$886.0M→$589.0M0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LVS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding decreased 7.3%
Shares outstanding changed -7.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
676,134,487→626,990,1338 prior comparisons
Net income decreased 27.4%
Net income changed -27.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$419.0M→$304.0M2 prior comparisons
Research & development decreased 48.6%
Research & development changed -48.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$72.0M→$37.0M2 prior comparisons
Operating margin moved 237 bp lower
Operating margin changed -237 basis points from the comparable as-filed period.
21.59%→19.22%2 prior comparisons
Operating cash flow decreased 22.0%
Operating cash flow changed -22.0% from the comparable as-filed period.
$1.1B→$870.0M0 prior comparisons
Trade receivables increased 21.2%
Trade receivables changed +21.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$548.0M→$664.0M4 prior comparisons
Operating income decreased 14.0%
Operating income changed -14.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$719.0M→$618.0M2 prior comparisons
Operating cash flow increased 283.1%
Operating cash flow changed +283.1% from the comparable as-filed period.
$178.0M→$682.0M1 prior comparisons
Operating margin moved 507 bp lower
Operating margin changed -507 basis points from the comparable as-filed period.
24.66%→19.59%2 prior comparisons
Operating income decreased 21.1%
Operating income changed -21.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$783.0M→$618.0M2 prior comparisons
Inventory increased 15.0%
Inventory changed +15.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$40.0M→$46.0M4 prior comparisons
Net income decreased 24.9%
Net income changed -24.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$461.0M→$346.0M2 prior comparisons
Research & development decreased 37.7%
Research & development changed -37.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$69.0M→$43.0M2 prior comparisons
Current liabilities increased 23.1%
Current liabilities changed +23.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$3.5B→$4.3B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.